CTI BioPharma Corp/ US12648L6011 /
2023-06-23 9:59:55 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
9.10USD | - | 88,647 Turnover: 805,837.44 |
-Bid Size: - | -Ask Size: - | 9.10 | 9.09 |
GlobeNewswire
2023-10-23
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
Newsfile Corp
2023-08-23
SEC Charges Former Attorney at U.S.-Based Global Law Firm with Insider Trading
GlobeNewswire
2021-03-17
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...
GlobeNewswire
2021-02-22
Adverum Appoints Esteemed Healthcare Executive Reed V. Tuckson, M.D., to Board of Directors
GlobeNewswire
2019-04-18
Research Report Identifies Fastenal, Ideal Power, Fuel Tech, CTI BioPharma, Aptevo Therapeutics, and...
GlobeNewswire
2018-12-10
Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer
GlobeNewswire
2016-11-28
Cascadian Therapeutics Strengthens Management Team with Key Hires, Monique M. Greer and Marc C. C...